UPDATE: Chardan Capital Markets Downgrades Seres Therapeutics (MCRB) to Neutral
Tweet Send to a Friend
(Updated - September 18, 2020 7:20 AM EDT)
(updating comment)Chardan Capital Markets analyst Taylor Feehley downgraded Seres Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Chardan Capital Markets analyst Taylor Feehley downgraded Seres Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
